Biotech executive urges prevention-focused response to fentanyl crisis
The U.S. is responding to fentanyl overdoses too late by focusing on reversing them after they start, rather than preventing the drug from taking effect, ARMR Sciences CEO Collin Gage said. He is calling for greater attention to an experimental fentanyl vaccine.
Gage urged the incoming Democrat-controlled Congress to build on President Donald Trump’s designation of illicit fentanyl as a weapon of mass destruction and make defenses against emerging synthetic drugs a national security priority.
“If you look at the overdose crisis like any other health crisis, really as a disease, you’ll know the best way to treat a crisis is by preventing it altogether,” Gage said. He argued that the country should shift toward preventive treatments instead of relying on approaches that, he said, have coincided with tens of thousands of deaths over recent years.
Gage described Trump’s designation as an important step toward a biodefense strategy. He said synthetic drugs such as fentanyl, carfentanil, nitazenes and medetomidine present a distinctive threat because they can be produced using information and materials found online, including through dark-web marketplaces.
Unlike substances such as sarin gas or anthrax, Gage said, these pharmaceutical-based agents can be formulated relatively quickly. He warned that the threat, which has caused extensive harm in the U.S., is beginning to spread internationally.
ARMR Sciences is conducting a Phase 1/2 clinical trial of its experimental fentanyl vaccine. The study is assessing its safety and how well it can prevent synthetic drugs from reaching the brain.
Gage said the broader goal is to improve protection for first responders. He also called on lawmakers to regard synthetic-drug defense as a national priority, not a partisan one, noting that fentanyl affects people across racial and economic lines.
Before the vaccine is considered for high-risk civilians, including college students, Gage said safety and transparency should come first. ARMR Sciences has publicly shared the vaccine’s formulation and did not include heavy metals. Gage connected that decision to Health and Human Services Secretary Robert F. Kennedy Jr.’s scrutiny of ingredients, and praised former Representative Patrick Kennedy’s work on addiction-treatment reform.
The issue is personal for Gage: his mother struggled with addiction, and he has lost friends to overdoses. He said he hopes to prevent other families from experiencing similar loss.
People experiencing substance-use problems, or those concerned about someone else, can contact the SAMHSA National Helpline at 1-800-662-4357. It is available 24 hours a day, seven days a week.



